Latest Insider Transactions at Fibro Biologics, Inc. (FBLG)
This section provides a real-time view of insider transactions for Fibro Biologics, Inc. (FBLG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of FibroBiologics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of FibroBiologics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2024
|
Hamid Khoja Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+47.06%
|
$10,000
$1.9 P/Share
|
|
Aug 12
2024
|
Pete O'Heeron Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
8,500
+0.14%
|
$8,500
$1.91 P/Share
|